Summit Therapeutics (SMMT) shares fell 37%, or $13.49, to $23.21 before halting for news. BioNTech (BNTX) dropped in sympathy, down 15% to $102.85.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMMT: